Mettler-Toledo International Inc. (NYSE:MTD) Short Interest Update

Mettler-Toledo International Inc. (NYSE:MTDGet Rating) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 491,700 shares, a growth of 21.9% from the March 15th total of 403,500 shares. Based on an average daily trading volume, of 127,200 shares, the short-interest ratio is presently 3.9 days. Approximately 2.2% of the company’s shares are short sold.

MTD traded up $26.46 during trading on Tuesday, hitting $1,331.04. The stock had a trading volume of 89,250 shares, compared to its average volume of 125,733. The stock has a 50 day simple moving average of $1,383.44 and a two-hundred day simple moving average of $1,467.80. The company has a market capitalization of $30.26 billion, a PE ratio of 39.75, a PEG ratio of 1.80 and a beta of 1.08. The company has a debt-to-equity ratio of 9.22, a quick ratio of 0.75 and a current ratio of 1.11. Mettler-Toledo International has a twelve month low of $1,225.56 and a twelve month high of $1,714.75.

Mettler-Toledo International (NYSE:MTDGet Rating) last posted its quarterly earnings data on Thursday, February 10th. The medical instruments supplier reported $10.53 earnings per share for the quarter, topping the Zacks’ consensus estimate of $10.07 by $0.46. Mettler-Toledo International had a return on equity of 438.50% and a net margin of 20.68%. The firm had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter last year, the firm earned $9.26 EPS. The business’s quarterly revenue was up 10.6% on a year-over-year basis. On average, equities research analysts anticipate that Mettler-Toledo International will post 38.36 EPS for the current year.

In other Mettler-Toledo International news, insider Peter Aggersbjerg sold 1,000 shares of the company’s stock in a transaction on Friday, March 4th. The stock was sold at an average price of $1,386.53, for a total value of $1,386,530.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Olivier A. Filliol sold 12,500 shares of the stock in a transaction on Wednesday, March 2nd. The stock was sold at an average price of $1,390.27, for a total value of $17,378,375.00. The disclosure for this sale can be found here. Insiders sold a total of 17,540 shares of company stock worth $24,552,512 in the last ninety days. 2.80% of the stock is currently owned by insiders.

Hedge funds have recently modified their holdings of the company. Fifth Third Bancorp raised its holdings in shares of Mettler-Toledo International by 19.2% in the first quarter. Fifth Third Bancorp now owns 292 shares of the medical instruments supplier’s stock worth $401,000 after buying an additional 47 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in Mettler-Toledo International by 6.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,312 shares of the medical instruments supplier’s stock valued at $8,568,000 after purchasing an additional 389 shares during the period. IFM Investors Pty Ltd lifted its position in shares of Mettler-Toledo International by 20.8% during the 1st quarter. IFM Investors Pty Ltd now owns 3,653 shares of the medical instruments supplier’s stock valued at $5,016,000 after buying an additional 628 shares in the last quarter. CAPROCK Group Inc. grew its stake in Mettler-Toledo International by 41.4% in the 1st quarter. CAPROCK Group Inc. now owns 188 shares of the medical instruments supplier’s stock valued at $258,000 after acquiring an additional 55 shares during the period. Finally, Veriti Management LLC increased its holdings in Mettler-Toledo International by 5.1% in the 1st quarter. Veriti Management LLC now owns 706 shares of the medical instruments supplier’s stock worth $969,000 after acquiring an additional 34 shares in the last quarter. Institutional investors and hedge funds own 92.56% of the company’s stock.

MTD has been the subject of a number of analyst reports. StockNews.com assumed coverage on Mettler-Toledo International in a report on Thursday, March 31st. They set a “buy” rating for the company. Robert W. Baird upped their price objective on Mettler-Toledo International from $1,531.00 to $1,595.00 in a research note on Friday, February 11th. Finally, The Goldman Sachs Group lowered Mettler-Toledo International from a “neutral” rating to a “sell” rating and set a $1,240.00 target price on the stock. in a research note on Thursday, March 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $1,471.75.

Mettler-Toledo International Company Profile (Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.